Resources for Eye Care Professionals

DOT White Paper

DOT™ Myopia Control Spectacle Lenses Available for Early Access in the U.K.

29 September 2025

DOT™ Lenses Worn by One Million Children

25 August 2025

New Studies Demonstrate 75% Myopia Management Efficacy with Chinese Children after 12 Months and No Evidence of Rebound Effect in North American Children for SightGlass Vision DOT™ Lenses

5 May 2025

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

9 December 2024

IMC 2024: Multiple Studies Reinforce SightGlass Vision 
Diffusion Optics Technology™ Efficacy¹ for Myopia Management

23 September 2024

SightGlass Vision Presents New Data at Academy ’23, Reinforcing Diffusion Optics Technology™ Myopia Control Impact

9 October 2023

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

20 September 2023

SightGlass Vision Reports Positive Four-Year Clinical Trial Outcomes for Myopia Control DOT Spectacle Lenses

5 September 2023

SightGlass Vision Presents New Myopia Control Science and Clinical Insights at 2023 BCLA Conference

6 June 2023

Please note that our products are not available for sale or distribution in every country in the world.
Our products are not available for sale in the U.S.